Afobazole Restores the Dopamine Level in a 6-Hydroxydopamine Model of Parkinson’s Disease
- Authors: Voronin M.V.1, Kadnikov I.A.1, Seredenin S.B.1
-
Affiliations:
- Zakusov Research Institute of Pharmacology
- Issue: Vol 13, No 1 (2019)
- Pages: 49-56
- Section: Experimental Articles
- URL: https://journals.rcsi.science/1819-7124/article/view/211639
- DOI: https://doi.org/10.1134/S1819712419010185
- ID: 211639
Cite item
Abstract
In this study, 5 µg of 6-hydroxydopamine (6-OHDA) were injected unilaterally into the striatum of mice. The mice were then treated intraperitoneally with afobazole at a dose of 2.5 mg/kg for 14 days starting 30 min after the 6-OHDA injection. The content of monoamines was studied in the striatum of the mice. Afobazole prevented a decrease in the dopamine level in the 6-OHDA-damaged striatum of the experimental animals and did not affect the contents of norepinephrine, serotonin, or its metabolites in the striatum of both the control and 6-OHDA-treated mice.
Keywords
About the authors
M. V. Voronin
Zakusov Research Institute of Pharmacology
Email: ikadnikov@gmail.com
Russian Federation, Moscow
I. A. Kadnikov
Zakusov Research Institute of Pharmacology
Author for correspondence.
Email: ikadnikov@gmail.com
Russian Federation, Moscow
S. B. Seredenin
Zakusov Research Institute of Pharmacology
Email: ikadnikov@gmail.com
Russian Federation, Moscow
Supplementary files
